Navigation Links
Bruin Biometrics Formalizes Management Structure with Appointment of Jeff Greiner and Eve Kurtin to Board of Directors, Plus Additional Executive Leadership

LOS ANGELES, Dec. 2, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") a medical device company developing innovative, point of care diagnostic devices, announced today the appointment of two new board members and the expansion of the executive team.


Jeff Greiner joins the BBI board after serving 18 years leading Advanced Bionics, a medical device company that developed spinal cord stimulators and cochlear implants. The company was sold for over $3 billion dollars and is now owned by Boston Scientific (neuromodulation division) and Sonova (cochlear implant division).

Eve Kurtin joins the BBI Board with over 20 years of experience as an operating executive and investor in healthcare. Eve is Managing Director of Pacific Venture Group and Senior Advisor of VantagePoint Capital Partners. She is also a founding member of the RAND Health Board of Advisors, an assembly of national leaders working to improve the U.S. healthcare system.

Rob Pecsar joins BBI as Vice President of Research & Development. Rob has previously launched 18 medical products at a variety of companies including Alaris Medical Systems, Cardinal Health, CareFusion, Gen-Probe, IMED, and Infrasonics, Inc.

Armin Beck joins BBI as Vice President of Quality, Regulatory, Manufacturing, and Operations. He has over 30 years experience leading international commercial product launches and most recently directed Quality Assurance, Regulatory, and Clinical Affairs at Cardica, Inc.

Mark Bruns joins BBI as Vice President of Commercial Operations and Sales. Mark has over 30 years of experience, most recently as a transformational leader in sales and marketing at Alaris Medical Systems, Cardinal Health, and CareFusion.

Sally Grigoriev joins BBI as Senior Advisor, Operations. Sally was previously Senior Vice President of Manufacturing and Operations at CareFusion and Cardinal Health.  She has over 25 years of R&D, Quality, Regulatory, Manufacturing, and Operations experience within the medical device industry.

BBI Chief Executive Martin Burns commented, "We have been extremely diligent about finding the right people who understand BBI's strategy and also have the talent to execute upon BBI's business goals. Our combined team has launched over 30 medical products and technologies, and we are united in our mission to solve pressing clinical challenges."

To learn more about BBI please visit

SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bruin Biometrics, LLC führt klinische Studie zum Nachweis von Druckgeschwüren mit dem SEM Scanner durch
2. Bruin Biometrics, LLC Conducts Clinical Trials to Detect Pressure Ulcers with the SEM Scanner
3. Bruin Biometrics, LLC Announces New Board Members
4. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
5. Biometrics Limits Abuse while Improving Convenience
6. Virtify Announces Second Webinar on Regulatory Information Management Strategies for Small and Mid-Sized Pharmas
7. Lorus Therapeutics Completes New Executive Management Team
8. The Modern Algorithm For Management Of Massive And Submassive Pulmonary Embolism
9. The Huntzinger Management Group, Inc. (HMG) Reporting Significant Growth and Business Expansion in 2013
10. Array BioPharma Announces Management Team Change
11. Implantable Medical Device Group formed to Reduce Risk and Simplify Management of Active Implant Projects
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):